The alliance of sphingosine-1-phosphate and its receptors in immunity
Open accessThe DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Sphingosine-1-phosphate (S1P) is a biologically active metabolite of plasma-membrane sphingolipids that is essential for immune-cell trafficking. Its concentration is increased in many inflammatory conditions, such as asthma and autoimmunity. Much of the immune function of S1P results from the engagement of a family of G-protein-coupled receptors (S1PR1-S1PR5). Recent findings on the role of S1P in immunosurveillance, the discovery of regulatory mechanisms in S1P-mediated immune-cell trafficking and new advances in understanding the mechanism by which S1P affects immune-cell function indicate that the alliance between S1P and its receptors has a fundamental role in immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The multiple biological activities of S1P are mediated by five distinct G protein-coupled receptors (S1PR1–5), which are differently expressed in various tissues163.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [163]
In the citing paper
“Sphingosine receptors play an important role in innate immune responses (120), and sphingosine analogs have shown potential for controlling the cytokine storm caused by influenza virus (95).”
From Into the Eye of the Cytokine Storm (2012) · cites this paper as [120]
Citations
Cites
1 retracted
Melendez, A. J., & Khaw, A. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110944200 · Cited by 159
RetractedPrinciples of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333 · cited 1×
“Two sphingosine kinases ( SPHK1 and SPHK2 ) then phosphorylate sphingosine to generate the lysosphingolipid sphingosine-1-phosphate (S1P”
BackgroundLymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Self-citationThe Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,504 · cited 1×
“A breakthrough in the understanding of its mechanism, together with a link to S1PR signalling, came with the realization that FTY720 is a sphingosine analogue that could be phosphorylated by SPHKs to produce a S1PR ligan”
BackgroundCD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
Shiow, L. R., Rosen, D. B., Brdičková, N., Xu, Y., An, J., Lanier, L. L., Cyster, J. G., & Matloubian, M. (2006) · Nature · doi:10.1038/nature04606 · Cited by 1,189
Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C.-X., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S.-S., Lee, M.-J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10905 · Cited by 1,149 · cited 1×
“Further support is provided by the well-documented role of S1PR1 in regulating endothelial-cell organization during developmen”
BackgroundSelf-citationOral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
Kappos, L., Antel, J., Comi, G., Montalban, X., O'Connor, P., Polman, C. H., Haas, T., Korn, A. A., Karlsson, G., & Radue, E. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052643 · Cited by 1,054 · cited 1×
“By contrast, treatment of patients with relapsing–remitting multiple sclerosis with considerably lower doses of FTY720 alone has proven to be beneficia”
ResultPromotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate
Pappu, R., Schwab, S. R., Cornelissen, I., Pereira, J. P., Regard, J. B., Xu, Y., Camerer, E., Zheng, Y.-W., Huang, Y., Cyster, J. G., et al. (2007) · Science · doi:10.1126/science.1139221 · Cited by 877
Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients
Schwab, S. R., Pereira, J. P., Matloubian, M., Xu, Y., Huang, Y., & Cyster, J. G. (2005) · Science · doi:10.1126/science.1113640 · Cited by 787 · cited 1×
“Notable exceptions are the blood, where S1P levels are in the low-micromolar range and are mainly contributed by erythrocytes, and the lymph, where S1P levels are in the hundred-nanomolar rang”
BackgroundEssential Role for Sphingosine Kinases in Neural and Vascular Development
Mizugishi, K., Yamashita, T., Olivera, A., Miller, G. F., Spiegel, S., & Proia, R. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.11113-11121.2005 · Cited by 742 · cited 1×
“More specifically, deletion of the genes that encode both kinases is embryonic lethal and results in embryos lacking S1”
BackgroundSelf-citation
Cited by
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940
“important role in innate immune responses (120)”
BackgroundRevisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
Sphingolipid metabolites in inflammatory disease
Maceyka, M., & Spiegel, S. (2014) · Nature · doi:10.1038/nature13475 · Cited by 1,277
Cell Biology of Cnidarian-Dinoflagellate Symbiosis
Davy, S. K., Allemand, D., & Weis, V. M. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05014-11 · Cited by 1,092
Astrocyte Crosstalk in CNS Inflammation
Linnerbauer, M., Wheeler, M. A., & Quintana, F. J. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.012 · Cited by 989
“S1P is a biologically active phospholipid generated from ceramide which controls proliferation of several cell types and leukocyte trafficking from lymphoid tissues into circulation (Rivera et al., 2008).”
BackgroundThe outs and the ins of sphingosine-1-phosphate in immunity
Spiegel, S., & Milstien, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri2974 · Cited by 810
Teijaro, J. R., Walsh, K. B., Cahalan, S., Fremgen, D. M., Roberts, E., Scott, F., Martinborough, E., Peach, R., Oldstone, M. B. A., & Rosen, H. (2011) · Cell · doi:10.1016/j.cell.2011.08.015 · Cited by 688
“Chemical modulators of the sphingosine-1-phosphate (S1P) signaling system have provided insight into immune cell trafficking and immune responses (Rivera et al., 2008; Rosen et al., 2009).”
BackgroundAtopic dermatitis: an expanding therapeutic pipeline for a complex disease
Bieber, T. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00266-6 · Cited by 623
Orm family proteins mediate sphingolipid homeostasis
Breslow, D. K., Collins, S. R., Bodenmiller, B., Aebersold, R., Simons, K., Shevchenko, A., Ejsing, C. S., & Weissman, J. S. (2010) · Nature · doi:10.1038/nature08787 · Cited by 599
Pathogenesis of Systemic Sclerosis
Pattanaik, D., Brown, M., Postlethwaite, B. C., & Postlethwaite, A. E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00272 · Cited by 405
STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors
Lee, H., Deng, J., Kujawski, M., Yang, C., Liu, Y., Herrmann, A., Kortylewski, M., Horne, D., Somlo, G., Forman, S., et al. (2010) · Nature Medicine · doi:10.1038/nm.2250 · Cited by 395
“The S1PR1 gene encodes one of the G protein–coupled receptors for S1P, a biologically active metabolite of sphingolipi”
BackgroundAn update on sphingosine-1-phosphate and other sphingolipid mediators
Fyrst, H., & Saba, J. D. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.392 · Cited by 344
The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR
Liu, G., Burns, S., Huang, G., Boyd, K., Proia, R. L., Flavell, R. A., & Chi, H. (2009) · Nature Immunology · doi:10.1038/ni.1743 · Cited by 339
“Sphingosine 1-phosphate (S1P) is a natural lysophospholipid with micromolar concentrations in the plasm”
BackgroundSelf-citationActivation of mTOR (mechanistic target of rapamycin) in rheumatic diseases
Perl, A. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.172 · Cited by 332
Chun, J., Hla, T., Lynch, K. R., Spiegel, S., & Moolenaar, W. H. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003111 · Cited by 330
“…2008; Rivera and Chun, 2008; Noguchi et al., 2009; Skoura and Hla, 2009; Teo et al., 2009; Choi et al., 2010), LPA enzymology (Moolenaar et al., 2004; Aoki et al., 2008), and S1P receptors (Saba, 2004; Chun, 2005; Kono et al., 2008; Rivera et al., 2008; Maceyka et al., 2009; Skoura and Hla, 2009).”
Fukuhara, S., Simmons, S., Kawamura, S., Inoue, A., Orba, Y., Tokudome, T., Sunden, Y., Arai, Y., Moriwaki, K., Ishida, J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60746 · Cited by 324
Watson, D. S., Endsley, A. N., & Huang, L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.070 · Cited by 322
The S1P1-mTOR axis directs the reciprocal differentiation of TH1 and Treg cells
Liu, G., Yang, K., Burns, S., Shrestha, S., & Chi, H. (2010) · Nature Immunology · doi:10.1038/ni.1939 · Cited by 321
“Sphingosine 1-phosphate (S1P) is a bioactive lysophospholipid enriched in blood 10 .”
Gaengel, K., Niaudet, C., Hagikura, K., Laviña, B., Muhl, L., Hofmann, J. J., Ebarasi, L., Nyström, S., Rymo, S., Chen, L. L., et al. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.08.005 · Cited by 317
HDL in innate and adaptive immunity
Catapano, A. L., Pirillo, A., Bonacina, F., & Norata, G. D. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu150 · Cited by 299
Membranes in Balance: Mechanisms of Sphingolipid Homeostasis
Breslow, D. K., & Weissman, J. S. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.005 · Cited by 287
“Furthermore, sphingolipids have a number of well-established roles in the lung and in modulating inflammatory processes and immune system function (Rivera et al., 2008; Ryan and Spiegel, 2008; Uhlig and Gulbins, 2008).”
BackgroundTargeting TGF-β signaling for the treatment of fibrosis
Györfi, A. H., Matei, A.-E., & Distler, J. H. W. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.12.016 · Cited by 274
Regulation of Mast Cell Responses in Health and Disease
Gilfillan, A. M., & Beaven, M. A. (2011) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v31.i6.30 · Cited by 259
Ratajczak, M. Z., Lee, H., Wysoczynski, M., Wan, W., Marlicz, W., Laughlin, M. J., Kucia, M., Janowska-Wieczorek, A., & Ratajczak, J. (2010) · Leukemia · doi:10.1038/leu.2010.53 · Cited by 253
Type I interferons in viral control and immune regulation
Teijaro, J. R. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.01.001 · Cited by 239
“Signaling through these five receptors is known to modulate multiple cellular functions including: cell adhesion, migration, survival, proliferation, endocytosis, barrier function and cytokine production [76].”
BackgroundEffector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire
Dimova, T., Brouwer, M., Gosselin, F., Tassignon, J., Leo, O., Donner, C., Marchant, A., & Vermijlen, D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412058112 · Cited by 228
Th1/Th2 Cell Differentiation and Molecular Signals
Zhang, Y., Zhang, Y., Gu, W., & Sun, B. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-017-9487-9_2 · Cited by 223
“This difference in producing and maintaining S1P cause the concentration gradients of S1P in blood and tissues, especially in the part with wound, inflammation or infection, and this gradients is very important in directing immune cells to migrant to where they are needed [24, 128, 130, 137, 147].”
BackgroundHuman Circulating and Tissue-Resident CD56bright Natural Killer Cell Populations
Melsen, J. E., Lugthart, G., Lankester, A. C., & Schilham, M. W. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00262 · Cited by 214
Tsai, H.-C., & Han, M. H. (2016) · Drugs · doi:10.1007/s40265-016-0603-2 · Cited by 211
“S1P1 expression is also associated with T cell activation status [6, 31].”
Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate
Gomez-Muñoz, A., Presa, N., Gomez-Larrauri, A., Rivera, I.-G., Trueba, M., & Ordoñez, M. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.09.002 · Cited by 209
Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential
Aoki, M., Aoki, H., Ramanathan, R., Hait, N. C., & Takabe, K. (2016) · Mediators of Inflammation · doi:10.1155/2016/8606878 · Cited by 210
Neural Crest–Derived Pericytes Promote Egress of Mature Thymocytes at the Corticomedullary Junction
Zachariah, M. A., & Cyster, J. G. (2010) · Science · doi:10.1126/science.1188222 · Cited by 208
Heng, B. C., Aubel, D., & Fussenegger, M. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.08.017 · Cited by 204
“…widely expressed on most immune cells (unlike the other four S1PR receptor subtypes with a more restricted distribution), the release of sphingosine-1-phosphate by mast cells also stimulates the chemotactic migration of other immune cells involved in the inflammatory process (Rivera et al., 2008).”
BackgroundMast Cells and Their Progenitors in Allergic Asthma
Méndez-Enríquez, E., & Hallgren, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00821 · Cited by 202
Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation
Hla, T., & Brinkmann, V. (2011) · Neurology · doi:10.1212/wnl.0b013e31820d5ec1 · Cited by 201
Targeting sphingosine-1-phosphate signaling in immune-mediated diseases: beyond multiple sclerosis
Pérez-Jeldres, T., Alvarez-Lobos, M., & Rivera-Nieves, J. (2021) · Drugs · doi:10.1007/s40265-021-01528-8 · Cited by 197
“Free S1P or albumin-bound S1P is more susceptible to degradation than S1P bound to lipoproteins [10].”
BackgroundInfluentialEmerging role of high density lipoproteins as a player in the immune system
Norata, G. D., Pirillo, A., Ammirati, E., & Catapano, A. L. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.045 · Cited by 192
“[142] Rivera J, Proia RL, Olivera A.”
BackgroundNon-IgE mediated mast cell activation
Yu, Y., Blokhuis, B. R., Garssen, J., & Redegeld, F. A. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.07.017 · Cited by 183
“Sphingosine-1-phosphate (S1P) is a biologically active metabolite of plasma-membrane sphingolipids, which is essential for immune-cell traf fi cking (Rivera et al., 2008).”
Sphingosine-1-phosphate and immune regulation: trafficking and beyond
Chi, H. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.11.002 · Cited by 178
S1P1 receptor directs the release of immature B cells from bone marrow into blood
Allende, M. L., Tuymetova, G., Lee, B. G., Bonifacino, E., Wu, Y.-P., & Proia, R. L. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092210 · Cited by 180
“Within the immune system, S1P receptor signaling has several roles in the regulation of innate and adaptive immune responses (Cyster, 2005; Rosen and Goetzl, 2005; Goetzl et al., 2008; Rivera et al., 2008).”
BackgroundSelf-citationAllende, M. L., Bektas, M., Lee, B. G., Bonifacino, E., Kang, J., Tuymetova, G., Chen, W., Saba, J. D., & Proia, R. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.171819 · Cited by 177
Self-citationMast Cell Chemotaxis – Chemoattractants and Signaling Pathways
Halova, I., Draberova, L., & Draber, P. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00119 · Cited by 176
“The lipid mediator S1P takes part in diverse biological processes, from vascular, and neural development to regulation of lymphocyte trafficking (Olivera, 2008; Rivera et al., 2008).”
BackgroundSphingosine 1-phosphate in coagulation and inflammation
Obinata, H., & Hla, T. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0287-3 · Cited by 174
“The reader interested is referred to excellent reviews by other authors [97, 114–121].”
Export and functions of sphingosine-1-phosphate
Kim, R. H., Takabe, K., Milstien, S., & Spiegel, S. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.02.011 · Cited by 172
“As this important area has been extensively discussed in several recent reviews [8,44, 45], it will not be covered here.”
BackgroundThangada, S., Khanna, K. M., Blaho, V. A., Oo, M. L., Im, D.-S., Guo, C., Lefrancois, L., & Hla, T. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091343 · Cited by 172
“…but also B cells, dendritic cells, NK cells, osteoclasts, and hematopoietic progenitor cells (Allende and Proia, 2002; Kabashima et al., 2006; Massberg et al., 2007; Schwab and Cyster, 2007; Walzer et al., 2007; Ledgerwood et al., 2008; Rivera et al., 2008; Sebzda et al., 2008; Ishii et al., 2009).”
BackgroundThe Transporter Spns2 Is Required for Secretion of Lymph but Not Plasma Sphingosine-1-Phosphate
Mendoza, A., Bréart, B., Ramos-Perez, W. D., Pitt, L. A., Gobert, M., Sunkara, M., Lafaille, J. J., Morris, A. J., & Schwab, S. R. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.021 · Cited by 167
“Although extracellular S1P in tissues is thought to be low in homeostasis, an influx of plasma S1P may be a powerful proinflammatory stimulus (Rivera et al., 2008).”
BackgroundFingolimod is a potential novel therapy for multiple sclerosis
Aktas, O., Küry, P., Kieseier, B., & Hartung, H.-P. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.76 · Cited by 167
Buggert, M., Nguyen, S., Salgado-Montes de Oca, G., Bengsch, B., Darko, S., Ransier, A., Roberts, E. R., del Alcazar, D., Brody, I. B., Vella, L. A., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aar4526 · Cited by 167
“One possible mechanism by which T cells can down-regulate CD69 is through extensive cycling, leading to increased KLF2 and S1PR1 expression (50).”
Garris, C. S., Wu, L., Acharya, S., Arac, A., Blaho, V. A., Huang, Y., Moon, B. S., Axtell, R. C., Ho, P. P., Steinberg, G. K., et al. (2013) · Nature Immunology · doi:10.1038/ni.2730 · Cited by 160
G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders
Wong, T., Li, G., Li, S., Gao, W., Chen, G., Gan, S., Zhang, M., Li, H., Wu, S., & Du, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01427-2 · Cited by 197
“Unlike S1PR1, S1PR5 is mainly detected in natural killer and dendritic cells.(268) S1PR5 expression on natural killer cells is critical for its egress from lymph nodes and bone marrow.”
BackgroundSphingosine-1-phosphate receptors and innate immunity
Bryan, A. M., & Del Poeta, M. (2018) · Cellular Microbiology · doi:10.1111/cmi.12836 · Cited by 157
Salas-Perdomo, A., Miró-Mur, F., Gallizioli, M., Brait, V. H., Justicia, C., Meissner, A., Urra, X., Chamorro, A., & Planas, A. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-44845-5 · Cited by 155
Mast Cell Biology: Introduction and Overview
Gilfillan, A. M., Austin, S. J., & Metcalfe, D. D. (2011) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-9533-9_1 · Cited by 154
Next generation of small molecules in inflammatory bowel disease
Olivera, P., Danese, S., & Peyrin-Biroulet, L. (2017) · Gut · doi:10.1136/gutjnl-2016-312912 · Cited by 154
Blaho, V. A., & Hla, T. (2011) · Chemical Reviews · doi:10.1021/cr200273u · Cited by 147
Sukocheva, O. A., Furuya, H., Ng, M. L., Friedemann, M., Menschikowski, M., Tarasov, V. V., Chubarev, V. N., Klochkov, S. G., Неганова, М. Е., Mangoni, A. A., et al. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107464 · Cited by 153
Juarez, J. G., Harun, N., Thien, M., Welschinger, R., Baraz, R., Peňa, A. D., Pitson, S. M., Rettig, M. P., DiPersio, J. F., Bradstock, K. F., et al. (2011) · Blood · doi:10.1182/blood-2011-04-348904 · Cited by 147
Price, M. M., Oskeritzian, C. A., Falanga, Y. T., Harikumar, K. B., Allegood, J. C., Alvarez, S. E., Conrad, D. H., Ryan, J. J., Milstien, S., & Spiegel, S. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.014 · Cited by 153
Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease
Gangoiti, P., Camacho, L., Arana, L., Ouro, A., Granado, M. H., Brizuela, L., Casas, J., Fabriàs, G., Abad, J. L., Delgado, A., et al. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.02.004 · Cited by 160
“Excellent reviews on the immune function of S1P have been recently published [180, 225-227].”
Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking
Mayol, K., Biajoux, V., Marvel, J., Balabanian, K., & Walzer, T. (2011) · Blood · doi:10.1182/blood-2011-06-362574 · Cited by 141
Decreased serum concentrations of sphingosine-1-phosphate in sepsis
Winkler, M. S., Nierhaus, A., Holzmann, M., Mudersbach, E., Bauer, A., Robbe, L., Zahrte, C., Geffken, M., Peine, S., Schwedhelm, E., et al. (2015) · Critical Care · doi:10.1186/s13054-015-1089-0 · Cited by 137
“S1P has pro- as well as antiinflammatory effects [8, 26].”
BackgroundSphingosine 1-Phosphate and Atherosclerosis
Kurano, M., & Yatomi, Y. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17010 · Cited by 136
A Pivotal Role of Vitamin B9 in the Maintenance of Regulatory T Cells In Vitro and In Vivo
Kunisawa, J., Hashimoto, E., Ishikawa, I., & Kiyono, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032094 · Cited by 132
“Vitamin B6 is required for the metabolic pathway of sphingosine 1-phosphate, a lipid mediator that regulates cell trafficking [15]; disruption of vitamin B6 function results in aberrant T-cell differentiation and cell trafficking in both systemic and intestinal compartments [16,17,18].”
BackgroundOsteoclast migration, differentiation and function: novel therapeutic targets for rheumatic diseases
Kikuta, J., & Ishii, M. (2012) · Rheumatology · doi:10.1093/rheumatology/kes259 · Cited by 150
Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain
Chen, Z., Doyle, T. M., Luongo, L., Largent‐Milnes, T. M., Giancotti, L. A., Kolar, G. R., Squillace, S., Boccella, S., Walker, J. K., Pendleton, A. L., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820466116 · Cited by 134
“Accordingly, both S1PR1 agonism and antagonism can inhibit lymphocyte migration from lymph nodes into the spinal cord to prevent or blunt neuroinflammatory processes associated with MS (44, 45) that could lead to reduced pain.”
BackgroundSphingolipid metabolism during Toll‐like receptor 4 (TLR4)‐mediated macrophage activation
Olona, A., Hateley, C., Muralidharan, S., Wenk, M. R., Torta, F. T., & Behmoaras, J. V. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15642 · Cited by 143
“The biology and production kinetics of bioactive sphingolipid metabolites and their receptors in macrophages have been reviewed elsewhere and will not be discussed in this review (Rivera et al., 2008; Weigert et al., 2019).”
BackgroundOkoye, I. S., Czieso, S., Ktistaki, E., Roderick, K., Coomes, S. M., Pelly, V. S., Kannan, Y., Perez-Lloret, J., Zhao, J. L., Baltimore, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406322111 · Cited by 130
“Following activation, lymphocyte egress from lymphoid tissue requires the down-regulation of S1pr1 (45).”
BackgroundSphingosine-1-Phosphate and Macrophage Biology—How the Sphinx Tames the Big Eater
Weigert, A., Olesch, C., & Brüne, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01706 · Cited by 141
“Once outside cells, S1P is recognized by a family of five distinct G-protein coupled receptors (S1PR1-5) that initiate autocrine, “inside-out,” or paracrine signaling (64).”
BackgroundHorton, B. L., Morgan, D. M., Momin, N., Zagorulya, M., Torres-Mejia, E., Bhandarkar, V., Wittrup, K. D., Love, J. C., & Spranger, S. (2021) · Science Immunology · doi:10.1126/sciimmunol.abi8800 · Cited by 132
Exploring Skin Wound Healing Models and the Impact of Natural Lipids on the Healing Process
Choudhary, V., Choudhary, M., & Bollag, W. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073790 · Cited by 146
“Specialized Pro-resolving Mediators (SPMs) such as Resolvin D2 (RvD2) and Lipoxin A4”
BackgroundSphingosine-1-phosphate receptor 2
Adada, M., Canals, D., Hannun, Y. A., & Obeid, L. M. (2013) · FEBS Journal · doi:10.1111/febs.12446 · Cited by 119
Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management
Oo, Y. H., Hübscher, S. G., & Adams, D. (2010) · Hepatology International · doi:10.1007/s12072-010-9183-5 · Cited by 130
Schulze, T., Golfier, S., Tabeling, C., Räbel, K., Gräler, M. H., Witzenrath, M., & Lipp, M. (2011) · The FASEB Journal · doi:10.1096/fj.10-179028 · Cited by 115
“Besides the S1P1 receptor, the S1P4 receptor is the predominant S1P receptor class expressed on many cells of the hematopoietic and immune system (29).”
BackgroundBagdanoff, J. T., Donoviel, M. S., Nouraldeen, A., Carlsen, M., Jessop, T. C., Tarver, J., Aleem, S., Dong, L., Zhang, H., Boteju, L., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101183p · Cited by 113
Oskeritzian, C. A., Price, M. M., Hait, N. C., Kapitonov, D., Falanga, Y. T., Morales, J. K., Ryan, J. J., Milstien, S., & Spiegel, S. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091513 · Cited by 112
“…metabolite sphingosine1–phosphate (S1P; Jolly et al., 2004; Mitra et al., 2006; Olivera et al., 2006), which has been implicated in initiation and maintenance of diverse aspects of immune cell activation and function (Rosen et al., 2008; for review see Schwab and Cyster, 2007; Rivera et al., 2008).”
Lipid phosphate phosphatase 3 enables efficient thymic egress
Bréart, B., Ramos-Pérez, W. D., Mendoza, A., Salous, A. K., Gobert, M., Huang, Y., Adams, R. H., Lafaille, J. J., Escalante‐Alcalde, D., Morris, A. J., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20102551 · Cited by 111
“Elevated S1P has been reported to promote angiogenesis and to enhance proinflammatory responses of innate and adaptive immune cells (Rivera et al., 2008; Liu et al., 2010).”
Gossens, K., Naus, S., Corbel, S. Y., Lin, S., Rossi, F. M. V., Kast, J., & Ziltener, H. J. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082502 · Cited by 108
“How can lymphocytes, which are only marginally involved in S1P production or degradation (18, 44), induce short-term changes in S1P levels? There is clear evidence that erythrocytes are one major source for plasma S1P, and although genetic evidence is still lacking, there are strong indications that DN3 thymocytes has…”
BackgroundLee, S. M.-Y., & Yen, H. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2012.09.013 · Cited by 114
“The binding of S1P to its receptors enables the control of a variety of cellular activities, including adhesion, migration, cytokine secretion and barrier integrity, and plays an important role in inflammation and immunity (Rivera et al., 2008).”
BackgroundOlivera, A., Eisner, C., Kitamura, Y., Dillahunt, S., Allende, L., Tuymetova, G., Watford, W., Meylan, F., Diesner, S. C., Li, L., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40659 · Cited by 107
Self-citationRatajczak, M. Z., Kim, C. H., Abdel‐Latif, A., Schneider, G., Kucia, M., Morris, A. J., Laughlin, M. J., & Ratajczak, J. (2011) · Leukemia · doi:10.1038/leu.2011.242 · Cited by 112
Regulation of macrophage function by sphingosine-1-phosphate
Weigert, A., Weis, N., & Brüne, B. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.06.003 · Cited by 111
“immune cell trafficking, it influences differentiation, survival and a broad repertoire of immune cell functions, which was reviewed in detail before (Goetzl et al. 2004; Rivera et al. 2008).”
Liesz, A., Sun, L., Zhou, W., Schwarting, S., Mracsko, E., Zorn, M., Bauer, H., Sommer, C., & Veltkamp, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021312 · Cited by 104
“Secondly, besides affecting the cellular migration of immune cells, S1P has distinct modulatory functions on their maturation and activation [48].”
BackgroundBouma, H. R., Kroese, F. G. M., Kok, J. W., Talaei, F., Boerema, A. S., Herwig, A., Draghiciu, O., van Buiten, A., Epema, A. H., van Dam, A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008823108 · Cited by 106
“Not only does S1P regulate the function of other types of leukocytes (31); it also is involved in other biological processes (32) and is implicated in governing protection against ischemia/reperfusion-induced injury in brain, heart, liver, and kidney (33–36).”
BackgroundRegulation of Ca2+ Signaling with Particular Focus on Mast Cells
Ma, H., & Beaven, M. A. (2009) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v29.i2.40 · Cited by 127
The Role of Sphingosine-1-Phosphate Transporter Spns2 in Immune System Function
Nijnik, A., Clare, S., Hale, C., Chen, J., Raisen, C., Mottram, L., Lucas, M., Estabel, J., Ryder, E., Adissu, H., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200282 · Cited by 99
Wang, Z., Lai, Y., Bernard, J. J., MacLeod, D. T., Cogen, A. L., Moss, B., & Di Nardo, A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101703 · Cited by 101
“When VV enter cells by membrane fusion, sphingomyelin and other phosphatidylserine lipids in VVenvelopes can be discharged in the MC membrane; the discharge will lead to a chain of events that includes the formation of S1P and activation of S1PR2.”
BackgroundInfluentialS1PR1 Is Crucial for Accumulation of Regulatory T Cells in Tumors via STAT3
Priceman, S. J., Shen, S., Wang, L., Deng, J., Yue, C., Kujawski, M., & Yu, H. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.016 · Cited by 99
“…receptor (GPCR) chemokine receptors, sphingosine-1 phosphate receptors (S1PR1-5) are also important regulators of immune cells, including T cells (Arnon et al., 2011; Rivera et al., 2008; Spiegel and Milstien, 2011), but their impact on tumor-associated T cells remains to be directly investigated.”
BackgroundMa, H., & Beaven, M. A. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9533-9_5 · Cited by 105
Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectin
Nußbaum, C., Bannenberg, S., Keul, P., Gräler, M. H., Gonçalves-de-Albuquerque, C. F., Korhonen, H., Lipinski, K. V. W., Heusch, G., Neto, H. C. D. C. F., Rohwedder, I., et al. (2015) · Nature Communications · doi:10.1038/ncomms7416 · Cited by 99
“8): (1) we provide evidence that S1P is a direct agonist of P-selectin mobilization and leukocyte rolling; (2) we identify S1P3 as the major responsible S1P receptor; (3) we show that several P-selectin agonists employ S1P and S1P3 as mediators of their P-selectin-mobilizing effects by activating Sphk1; (4) we P -s el…”
BackgroundInfluentialRegulation of vascular physiology and pathology by the S1P2 receptor subtype
Skoura, A., & Hla, T. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvp088 · Cited by 101
Weigert, A., Schiffmann, S., Sekar, D., Ley, S., Menrad, H., Werno, C., Grösch, S., Geißlinger, G., & Brüne, B. (2009) · International Journal of Cancer · doi:10.1002/ijc.24594 · Cited by 97
“Immunosuppressive properties of S1P were described for literally all immune cell populations.(35) Therefore, it is likely”
BackgroundKim, C., Schneider, G., Abdel‐Latif, A., Mierzejewska, K., Sunkara, M., Borkowska, S., Ratajczak, J., Morris, A. J., Kucia, M., & Ratajczak, M. Z. (2012) · Stem Cells · doi:10.1002/stem.1291 · Cited by 101
Cholesterol and Sphingolipid Enriched Lipid Rafts as Therapeutic Targets in Cancer
Codini, M., Garcia‐Gil, M., & Albi, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020726 · Cited by 105
“However, the utility of targeting S1P in tumors is hindered by the role of S1P1 on immune cell trafficking [54].”
BackgroundJiang, Z., Yin, X., & Jiang, Q. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002342 · Cited by 95
The role of sphingolipids in respiratory disease
Yang, Y., & Uhlig, S. (2011) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465811406772 · Cited by 93
“Of note, the effect of S1P may depend on the concentration of S1P, such that low concentrations promote and high concentrations block it (reviewed by Rivera and colleagues [Rivera et al. 2008]); a bell shaped concentration response curve is typical for many chemokines [Ludwig et al. 1997].”
BackgroundShaping the landscape: Metabolic regulation of S1P gradients
Olivera, A., Allende, M. L., & Proia, R. L. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.06.007 · Cited by 104
“For instance, experimental evidence suggests that S1P can skew responses toward allergic phenotypes by causing a shift toward TH2- and TH17-cell responses while disfavoring TH1-cell responses [1].”
BackgroundInfluentialSelf-citationCeramide in apoptosis and oxidative stress in allergic inflammation and asthma
James, B. N., Oyeniran, C., Sturgill, J., Newton, J. C., Martin, R., Bieberich, E., Weigel, C., Maczis, M. A., Palladino, E. N. D., Lownik, J. C., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.10.024 · Cited by 94
Rules and mechanisms governing G protein coupling selectivity of GPCRs
Masuho, I., Kise, R., Gainza, P., Von Moo, E., Li, X., Tany, R., Wakasugi-Masuho, H., Correia, B. E., & Martemyanov, K. A. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113173 · Cited by 87
Bajwa, A., Huang, L., Ye, H., Dondeti, K. R., Song, S., Rosin, D. L., Lynch, K. R., Lobo, P. I., Li, L., & Okusa, M. D. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200999 · Cited by 93
“S1P regulates migration of immune cells and could play a role in migration of DCs in S1P3-dependent kidney injury (70).”
BackgroundDistinct Roles of Sphingosine Kinase 1 and 2 in Murine Collagen-Induced Arthritis
Lai, W.-Q., Irwan, A. W., Goh, H. H., Melendez, A. J., McInnes, I. B., & Leung, B. P. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804376 · Cited by 89
“SphK/S1P exert pleiotropic effects on a variety of leukocyte subsets such as the T and B cells, macrophages, monocytes, and neutrophils (2, 4).”
BackgroundInfluential
Metadata
- Authors
- Rivera, J., Proia, R. L., & Olivera, A.
- Affiliations
- National Institutes of Health (US)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (US)
- Corresponding author
- Rivera, Juan
- Venue
- Nature Reviews Immunology
- Published
- 2008-10
- Volume
- 8
- Issue
- 10
- Pages
- 753-763
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2600775
- OpenAlex
- W1967802627
- Cited by
- 616
- References
- 108
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 18 · 2023: 30 · 2022: 26 · 2021: 38 · 2020: 30 · 2019: 40 · 2018: 37 · 2017: 34 · 2016: 41 · 2015: 36 · 2014: 46 · 2013: 46 · 2012: 58
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (Z01AR041155)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- sphingosine-1-phosphate, S1P receptors, G protein-coupled receptors, immune cell trafficking, immunomodulation, immune surveillance, immune cell function, inflammation, asthma, autoimmunity, sphingolipids
- MeSH terms
- Animals, Cell Movement, Chemotaxis, Dendritic Cells, Humans, Lymphocytes, Lysophospholipids, Macrophages, Mast Cells, Sphingosine, Signal Transduction, Receptors, Lysosphingolipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.